Friday, July 31, 2026

GCCL Strengthens Global Clinical Trial Role: What This Means for Asia’s Biotech Industry?

GCCL aims to expand internationally as a central lab for clinical trials, enhancing services and leveraging competitive advantages.

Unlocking AI: How SK Telecom’s New 100MW Data Center is Revolutionizing the Industry

SK Telecom's CTO highlights AI data centers as vital infrastructure, emphasizing rapid transformations in energy and server architectures.

Navigating Tariff Refunds: Key Insights for 6,000 South Korean Companies After U.S. Supreme Court Ruling

Korean exporters face uncertainty over tariff refunds after the U.S. Supreme Court ruling, fearing retaliation from the Trump administration.

Tag: orforglipron

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.